Refine by
Disease Management Articles & Analysis
137 news found
This technique combines the selectivity of antibodies with the potency of cytotoxic drugs, allowing for a highly focused approach to disease management, especially in oncology research. Additionally, CD Formulation offers Peptide Drug Conjugates (PDCs) service, which utilize homing peptides to streamline drug delivery to overexpressed protein receptors on tumor ...
Regular intake has been demonstrated to reduce symptoms of depression and anxiety, enhance fetal brain development, and lower heart disease risks by managing cholesterol and blood pressure levels. At present, high-quality omega fatty acids such as algae oil DHA and eicosapentaenoic acid (EPA) are easily accessible as raw materials at Alfa Chemistry. Phytosterols ...
In vitro diagnostics (IVD) are tests done on samples such as blood or tissue for the purpose of detecting diseases or other conditions. To facilitate efforts on IVD research, the US-based chemical supplier Alfa Chemistry has recently introduced three IVD products for laboratory use, adding to its already diverse range of biological reagents. ...
Antibacterial, Anti-inflammatory and Antiviral SeriesIn response to the global threat of infectious diseases, CD Formulation has developed a comprehensive range of APIs with antibacterial, anti-inflammatory and antiviral properties. ...
” Jack Syage, PhD and CEO of ImmunogenX, states, “We are excited by the continued success of latiglutenase as a leading therapeutic candidate for celiac disease patients as an adjunct to a gluten-free diet. Our mission to improve the lives of celiac disease patients is inspired by members of our team who are afflicted with this ...
Researchers at Dana-Farber Cancer Institute showed that enumeration of circulating tumor cells (CTCs) with Menarini Silicon Biosystems’ CELLSEARCH® System and the CELLSERCH® Circulating Multiple Myeloma Cell (CMMC) Test* can be used to monitor and manage patients with Multiple Myeloma (MM) even at asymptomatic precursor stages Menarini Silicon Biosystems, a pioneer ...
High demand seen for effective disease management platform for second most common cancer in Singaporean men NEW YORK and SINGAPORE, March 28, 2022 /PRNewswire/ -- miR Scientific, a New York-based healthcare company dedicated to transforming global cancer management, and Leonie Hill Capital, a Singapore-based organization focused on large-scale, ...
OCT fundus cameras like the Topcon Maestro2 allow us to see a greater detailed image of the eye to find pathology and manage diseases early.” By cross-cutting the retina in a manner similar to an MRI machine, OCT’s high-resolution imaging creates a 3D map of a patient’s eye, enabling doctors to diagnose eye diseases in a single ...
CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management. CAP accreditation is then awarded to facilities that meet the highest standards of quality in laboratory services. ...
Altoida, Inc., the precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced that management will be presenting at the upcoming conferences: BioFuture Panel Title: New Diagnostics: Revolutionizing Care in Alzheimer’s Date/Time: Wednesday, Nov. 9, ...
“These data are a significant milestone in our quest to make GBM a non-lethal and manageable disease.” ...
From early detection and diagnosis of disease to individualized treatment plans based on a person’s unique biology, medical care depends on accurate and timely health data. ...
Liver function tests are essential for the early diagnosis of liver disease and the management of patients with liver insufficiency. A number of enzymatic reactions have been developed to detect the presence of abnormal substances associated with different types of liver disease or liver damage. ...
The miR Sentinel™ Test assesses the risk of aggressive prostate cancer and is intended to aid in the detection and clinical management of men >45 years of age at risk for prostate cancer. "An estimated 268,490 men will be diagnosed with prostate cancer in 2022 according to the American Cancer Society. miR Scientific's vision is to revolutionize prostate cancer ...
The trial, MOOD, will assess the safety and efficacy of Relivion DP as an adjunctive treatment to pharmaceutical management of MDD in adults who have not achieved satisfactory improvement from antidepressant medications. ...
Hemophilia A is caused by the lack of the blood clotting factor VIII (FVIII), a protein whose instructions are provided by F8, a gene that is mutated in people with the disease. ASC618 is designed to deliver a shortened, but optimized version of the gene to liver cells. ...
Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced that Fran Soistman has joined the company’s Scientific Advisory Board (SAB). ...
The miR Sentinel™ Test assesses the risk of aggressive prostate cancer and is intended to aid in the clinical management of men >45 years of age at risk for prostate cancer. The results of a recent clinical study performed at multiple sites within the US and Puerto Rico were presented at the 2022 American Urological Association's Annual Meeting. ...
“The Relivion neuromodulation technology combined with the system’s remote monitoring platform has the opportunity to revolutionize the way migraine disease is managed”, said Amit Dar, Neurolief’s co-founder and CTO. ...
(“Neuropathix” or the “Company”) (OTCQB:NPTX), a socially responsible pain management life sciences company, announced today that it has reached an important milestone in the company’s history. ...